| Active Market | Forge Price1 | Last Funding Round | Trade Eligibility | ||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Company | Sector & Subsector | Market Activity4   |
Highest Bid | Lowest Ask | Last Matched | +/- to LFR | $ Total Bids |
$ Total Asks |
# Bids |
# Asks |
Current Price |
6-month |
1-year |
Total Funding |
Round | Date | Amount Raised |
Post-Money Valuation3 |
Price |
Key Investors | Common | Preferred | Fund | ||
 | Spyglass Pharma | Healthcare Medical Devices | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $200.88M | Series D | 6/2/2025 | $77.33M | $363.51M | $13.33 | Sands Capital, Gilde Healthcare, New Enterprise Associates, RA Capital Management, Censana Capital, Samsara BioCapital, Vertex Ventures HC | ||||
 | Stedi | Enterprise Software Productivity | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $138.91M | Series C | 3/24/2026 | $50M | $353.32M | $11.45 | Addition, Stripe, Ribbit Capital, Union Square Ventures, First Round Capital, BoxGroup, Bloomberg Beta, Tobi Lutke, Charlie Songhurst, Guillermo Rauch, Karim Atiyeh, Max Mullen, Jack Altman | ||||
 | Stepful | Healthcare Healthcare Software | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $103.91M | Series C | 6/8/2026 | $52.97M | $475.35M | $26.68 | Oak HC/FT, Foresite Capital, Hearst Ventures, Citi, SemperVirens, Y Combinator, Intermountain Health, ECMC Group | ||||
 | Stuut | Fintech Fintech Software | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $103.05M | Series B | 9/3/2026 | $62.5M | $353.67M | $11.59 | Insight Partners, Andreessen Horowitz, M12, Activant Capital | ||||
 | Synack | Enterprise Software Cybersecurity | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $112.56M | Series D | 5/28/2020 | $52M | $413.93M | $3.83 | B Capital Group, C5 Capital, GGV Capital, GV, Hewlett Packard Enterprise, Icon Ventures, Intel Capital, Kleiner Perkins, M12, Singtel Innov8 | ||||
 | Tasklet | Enterprise Software Productivity | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $29.5M | Series A-2 | 4/7/2026 | $18.5M | $175M | $6.92 | Union Square Ventures, Lightspeed Venture Partners, Y Combinator, Jeff Dean, Patrick Collison, John Collison | ||||
 | Tenvie | Healthcare Biotech & Pharma | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $200M | Series A | 1/8/2025 | $158.05M | $391.74M | $1.00 | ARCH Venture Partners, F-Prime Capital, Mubadala Capital | ||||
 | TeraDAR | Transportation Autonomous Vehicles | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $175.27M | Series B-3 | 11/12/2025 | $81.21M | $415.44M | $7.89 | VXI Capital Management, Capricorn Investment Group, Lockheed Martin, Ibex Investors | ||||
 | Treasury Prime | Fintech Fintech Software | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $72.52M | Series C | 2/1/2023 | $40M | $356.39M | $9.92 | BAM Elevate, The Banc Funds Company, Invicta, Deciens, QED, SaaStr | ||||
 | TriGemX Bio | Healthcare Biotech & Pharma | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $573.45M | Series E | 10/1/2026 | $93.99M | $341.19M | $0.79 | The Column Group, TCGX, Viking Global Investors | ||||
 | Uhnder | Transportation Autonomous Vehicles | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $200.18M | Series 2b | 2/21/2024 | $21.92M | $349.7M | $0.06 | ACME Capital, Magna, Qualcomm Ventures, El Camino Capital, Monta Vista Capital, Sagitta Ventures, HT Capital | ||||
 | Valence | Enterprise Software Productivity | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $80.48M | Series B-1 | 9/25/2025 | $47.5M | $265.47M | $9.31 | Bessemer Venture Partners | ||||
 | VitalConnect | Healthcare Medical Devices | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $308.06M | Series G-1 | 2/19/2025 | $33.85M | $451.12M | $0.42 | Ally Bridge Group, EW Healthcare Partners, MVM Life Sciences, Revelation Partners | ||||
 | Vouch | Fintech Insurance | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $205.43M | Series D-1 | 2/13/2025 | $18.5M | $306.49M | $2.40 | Allegis Capital | ||||
 | WildType | Foodtech Animal-Free Protein | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $9M | Series Seed Prime-1 | 3/25/2026 | $9M | $13.92M | $0.53 | Undisclosed Investors | ||||
 | WorkBoard | Enterprise Software Business Operations | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $157.48M | Series D-1 | 5/27/2025 | $9M | $101.9M | $0.33 | Undisclosed Investors | ||||
 | Zinier | Enterprise Software Productivity | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $126.16M | Series D | 11/17/2025 | $10M | $54.52M | $112.45 | Undisclosed Investors | ||||
 | 280 earth | Industrial Manufacturing | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $112.73M | Series B | 5/20/2024 | $50M | $249.19M | $2.09 | -- | ||||
 | Adonis | Enterprise Software Productivity | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $94M | Series C | 3/25/2026 | $40M | $325.2M | $10.10 | Quadrille Capital, General Catalyst, Bling Capital, The K Funds | ||||
 | Aerin Medical | Healthcare Medical Devices | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $172.7M | Series G | 1/13/2025 | $32.82M | $342.42M | $1.17 | KCK MedTech, Questa Capital, OrbiMed, Ally Bridge Group, Ares Capital | ||||
 | Aescape | Industrial Robotics | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $43.68M | Series A-1 | 4/6/2026 | $24.04M | $83.88M | $2.55 | Undisclosed Investors | ||||
 | Agrani Labs | Industrial Other Industrial | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $8.1M | Series Seed | 1/29/2026 | $8.1M | $33.21M | $2.34 | Peak XV Partners | ||||
 | AIRNA | Healthcare Medical Devices | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $245.25M | Series B | 4/1/2025 | $155M | $330.71M | $0.93 | Venrock, Forbion, RTW Investments, Nextech Invest, ARCH Venture Partners, ND Capital | ||||
 | Alt | Fintech Capital Markets | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $106.44M | Series B | 11/11/2021 | $75.63M | $326.32M | $10.56 | Spearhead, Seven Seven Six, Vibe Capital, Breyer Capital, Shrug Capital, Apollo Projects, Hyperguap, A* | ||||